Bioorganic and Medicinal Chemistry Letters p. 1057 - 1059 (2011)
Update date:2022-09-26
Topics:
Wang, Hongliang
Xiao, Junhai
Gao, Dapeng
Zhang, Xian
Yan, Hui
Gong, Zehui
Sun, Tinmin
Li, Song
A series of chloro-pyridazine piperazines were developed based on the structure of human rhinovirus (HRV) capsid-binding inhibitors with proven activity using a pharmacophore model. A preliminary evaluation demonstrated potent activity against HRV-3 with low cytotoxicity. A docking analysis indicated that 8a could fit into, and form tight interactions (e.g., H-bonds, σ-π effect) with the active site in VP1.
View MoreHuaihua Baohua Biotechnology Co.,Ltd
website:http://www.baochengchem.com
Contact:86-519-82698291
Address:HouYang chemical development zone,Jintan,Jiangsu,China (213200)
Tianjin Pharmacn Medical Technology Co.,Ltd.
Contact:86-22-60122566ext.866(English),23359620
Address:Green Industrial Base, 6 Haitaifazhan Sixth Rd., Huayuan Industrial Area, Tianjin, 300384, China
Shandong Dayi Chemical Co., Ltd.
website:http://www.dayi.com.cn
Contact:+86- 535-7388728. 15306386031
Address:No 1 Danya west road, Laiyang City, Shandong province
website:http://www.tbbmed.com
Contact:86--21-50498136
Address:Room 6002, Building 7-1, No.160 Basheng Road,Pudong Area,Shanghai China
Shenyang Mole pharmaceutical Technology Development Co.,Ltd
Contact:+86-24-31204918/13889278616
Address:No.44, wanliutang road, shenhe District of Shenyang
Doi:10.1016/j.cclet.2010.09.033
(2011)Doi:10.1016/j.bmc.2011.01.009
(2011)Doi:10.1002/adsc.201400457
(2014)Doi:10.3762/bjoc.7.5
(2011)Doi:10.1007/s00044-011-9553-0
(2012)Doi:10.1002/cmdc.201900023
(2019)